Check out our news archive below to learn more about what’s happening in Duke Psychiatry & Behavioral Sciences!
Hormone Widely Used as an Autism Treatment Shows No Benefit
Oxytocin, a naturally occurring hormone that acts as a chemical messenger in the brain, showed no evidence of helping children with autism gain social skills, according to a large national study published in the New England Journal of Medicine.
Beth Glascock, MPA, Joins Duke Psychiatry as Vice Chair for Administration & Finance
Beth Glascock, MPA, joined the Department of Psychiatry & Behavioral Sciences as our new Vice Chair for Administration and Finance on October 1.
Two Duke Brain Scientists Named Howard Hughes Investigators
Kafui Dzirasa, MD, PhD, the K. Ranga Rama Krishnan Associate Professor in the Department of Psychiatry & Behavioral Sciences, has been named a Howard Hughes Medical Institute (HHMI) investigator.
The Helpful Qualities of Quick Doses of Quiet
Duke Psychiatry's Dr. Jason Cho says we need to be intentional about creating opportunities to be quiet and still, especially in the Zoom era. Check out the great tips in this article for both relaxing and energizing ourselves.
Q&A with Shelley Holmer on the New Behavioral Health Center
In this Q&A, Duke Psychiatry's Shelley A. Holmer, MD, explains how the new behavioral health center meets a critical population health need in the region, the unique benefits to patients, and how providers can best refer their patients for assessment and treatment.
Smoking Abstinence Could Lower Effects of Cannabis on Sperm
While marijuana use may impact some genes linked to autism in men’s sperm, abstaining from cannabis consumption over time may significantly lower many of those effects, according to a study by Duke Health researchers.
Duke and UCLA Investigators Approved for Study on Youth Suicide Prevention
A team co-led by David Goldston, PhD, Associate Professor of Psychiatry and Behavioral Sciences at Duke University, and Joan Asarnow, PhD, Professor of Psychiatry and Biobehavioral Sciences at UCLA, has been approved for a $13 million award by the Patient-Centered Outcomes Research Institute.
New Screening Tool Improves Ability to Identify Patients at Risk of Suicide
A suicide screening tool developed by researchers from Duke Psychiatry and the Department of Veterans Affairs is far more accurate at identifying patients at risk for attempting suicide than current clinical assessments, which often have poor accuracy rates that can lead to the loss of life.
Consultation Line Expands Behavioral Health Care Access
NC-PAL is a free provider-to-provider consultation line and education program available to all clinicians across the state for questions about behavioral health or psychiatric medication management for their pediatric and perinatal patients.
Duke/UNC Awarded Grant to Establish Joint Alzheimer’s Disease Research Center
Duke University and the University of North Carolina at Chapel Hill have been awarded funds from the National Institutes of Health to establish a prestigious Alzheimer’s Disease Research Center, part of a federally-funded national network of similar centers.